Business Description
AngioDynamics Inc
NAICS : 339112
SIC : 3841
ISIN : US03475V1017
Share Class Description:
ANGO: Ordinary SharesTotal Employee Number:
675Description
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.67 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.5 | |||||
Beneish M-Score | -2.94 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.1 | |||||
3-Year EBITDA Growth Rate | -46.8 | |||||
3-Year EPS without NRI Growth Rate | 30.5 | |||||
3-Year FCF Growth Rate | -6.6 | |||||
3-Year Book Growth Rate | -25.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 39.86 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.2 | |||||
9-Day RSI | 62.22 | |||||
14-Day RSI | 62.23 | |||||
3-1 Month Momentum % | 6.5 | |||||
6-1 Month Momentum % | -13.41 | |||||
12-1 Month Momentum % | 16.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.35 | |||||
Quick Ratio | 1.47 | |||||
Cash Ratio | 0.57 | |||||
Days Inventory | 158.59 | |||||
Days Sales Outstanding | 50.96 | |||||
Days Payable | 81.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.5 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 54.3 | |||||
Operating Margin % | -6.52 | |||||
Net Margin % | -10.01 | |||||
EBITDA Margin % | 0.87 | |||||
FCF Margin % | 0.48 | |||||
OCF Margin % | 1.42 | |||||
ROE % | -17.49 | |||||
ROA % | -11.53 | |||||
ROIC % | -12.36 | |||||
3-Year ROIIC % | 2.59 | |||||
ROC (Joel Greenblatt) % | -26.24 | |||||
ROCE % | -10.21 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.72 | |||||
PB Ratio | 3.15 | |||||
Price-to-Tangible-Book | 5.05 | |||||
Price-to-Free-Cash-Flow | 335.64 | |||||
Price-to-Operating-Cash-Flow | 120.09 | |||||
EV-to-EBIT | -24.5 | |||||
EV-to-EBITDA | 182.82 | |||||
EV-to-Revenue | 1.6 | |||||
EV-to-Forward-Revenue | 1.52 | |||||
EV-to-FCF | 333.4 | |||||
Price-to-GF-Value | 1.57 | |||||
Price-to-Projected-FCF | 29.75 | |||||
Price-to-Median-PS-Value | 1.01 | |||||
| Price-to-Net-Current-Asset-Value | 7.98 | |||||
Earnings Yield (Greenblatt) % | -4.08 | |||||
FCF Yield % | 0.28 | |||||
Forward Rate of Return (Yacktman) % | 1.53 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ANGO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AngioDynamics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 313.725 | ||
| EPS (TTM) ($) | -0.75 | ||
| Beta | 0.3684 | ||
| 3-Year Sharpe Ratio | 0.29 | ||
| 3-Year Sortino Ratio | 0.46 | ||
| Volatility % | 35.11 | ||
| 14-Day RSI | 62.23 | ||
| 14-Day ATR ($) | 0.453552 | ||
| 20-Day SMA ($) | 12.4935 | ||
| 12-1 Month Momentum % | 16.93 | ||
| 52-Week Range ($) | 8.36 - 13.99 | ||
| Shares Outstanding (Mil) | 41.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AngioDynamics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AngioDynamics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| First quarter earnings conference call for 2027 | 2026-10-02 08:00 | In 89 days | ||
| First quarter earnings results for 2027 | 2026-10-02 | In 88 days | ||
| General meeting for 2026 | 2026-07-23 09:00 | In 18 days | ||
| Annual report for 2026 | 2026-07-17 | In 11 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-07-14 08:00 | In 9 days | ||
| Fourth quarter earnings results for 2026 | 2026-07-14 | In 8 days | ||
| Goldman Sachs 47th Annual Global Healthcare Conference | 2026-06-10 09:20 | 12.34 (+3.26%) | ||
| 25th Annual Needham Virtual Healthcare Conference | 2026-04-14 08:45 | 10.24 (+5.35%) | ||
| Third quarter earnings conference call for 2026 | 2026-04-02 08:00 | 11.94 (+4.46%) | ||
| Third quarter earnings results for 2026 | 2026-04-02 | 11.94 (+4.46%) |
Show
Entries
AngioDynamics Inc Frequently Asked Questions
What is AngioDynamics Inc(ANGO)'s stock price today?
The current price of ANGO is $13.09. The 52 week high of ANGO is $13.99 and 52 week low is $8.36.
When is next earnings date of AngioDynamics Inc(ANGO)?
The next earnings date of AngioDynamics Inc(ANGO) is 2026-07-14.
Does AngioDynamics Inc(ANGO) pay dividends? If so, how much?
AngioDynamics Inc(ANGO) does not pay dividend.
Guru Commentaries on NAS:ANGO
No articles.
Press Release
Articles on AngioDynamics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers